Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.
Fujiwara K, Kondo T, Fujimoto K, Yumita S, Ogawa K, Ishino T, Nakagawa M, Iwanaga T, Tsuchiya S, Koroki K, Kanzaki H, Inoue M, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Ogasawara S, Nakamoto S, Chiba T, Koizumi J, Kato J, Kato N.
Fujiwara K, et al. Among authors: nakagawa m.
J Gastroenterol. 2024 Apr 7. doi: 10.1007/s00535-024-02097-9. Online ahead of print.
J Gastroenterol. 2024.
PMID: 38583112